FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for COREG CR (carvedilol phosphate) from Waylis Therapeutics LLC, approving the controlled-release formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Post-myocardial Infarction

Drugs mentioned

• COREG CR (carvedilol phosphate)

Snippet

SUPPL AP for COREG CR (CARVEDILOL PHOSPHATE)